InvestorsHub Logo
Post# of 253344
Next 10
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: None

Sunday, 11/10/2013 11:59:46 AM

Sunday, November 10, 2013 11:59:46 AM

Post# of 253344
MK-8931 BACE inhibitor enrollment has begun



Phase-2/3 study in mild to moderate Alzheimer's Disease patients.





http://clinicaltrials.gov/ct2/show/NCT01739348?term=MK-8931&rank=2







Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.